Health Matters Newsletter: Health, access and the conditions around us - The Hindu
• A U.S. study highlights the high economic burden of measles outbreaks, estimating that a single event can cost millions of dollars in healthcare and public-health response. • Global health efforts are shifting toward infectious disease preparedness, including the U.S. FDA's approval of Moderna’s first mRNA influenza vaccine. • In India, research suggests that implementing a hexavalent vaccine could enhance the national immunisation programme, while ICAR has developed an indigenous vaccine for African swine fever.
thehindu.com




